Relevant Disclosures are Attached

%2 Fortis M A L A R HOSPITAL FMHL/SE/BM/NOV’26 November 03, 2026 BSE Limited Department of Corporate Services, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400001 Scrip Code: 523696 Subject: Outcome of Board Meeting in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to the provisions of Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosures Requirement) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e. Tuesday, November 03, 2026, inter-alia, considered and approved the Un-Audited (Standalone and Consolidated) Financial Results of the Company for the quarter and half year ended September 30, 2026. Accordingly, please find enclosed herewith Un-Audited (Standalone and Consolidated) Financial Results of the Company along with Limited Review report given by the Statutory Auditor of the Company for the quarter and half year ended September 30, 2026. The Board Meeting commenced at 11:00 AM (IST) and concluded at 02:50 PM (IST). This is for your information and record please. Thanking You, For Fortis Malar Hospitals Limited Vinti Verma Company Secretary & Compliance Officer M. No. A44528 Encl: As stated above FORTIS MALAR HOSPITALS LIMITED Regd. Office: Fortis Hospital, Sector 62, Pha—s VIel Mohali— 160062 Tel: +91 172 4692222 Fax: +91 172 5096002 CIN: L85110PB1989PLC045948 Email: secretarial.malar @malarhospitals.in Website: www.fortismalarhospital.com BSR&Co. LLP BLF Cpoeiyr, Prase Gurugram - 122 002, India Chartered Accountants Tel: +91 124 719 1000 Fax: +91 124 235 8613 Limited Review Report on unaudited consolidated financial results of Fortis Malar Hospitals Limited for the quarter ended 30 September 2026 and year to date results for the period from 01 April 2026 to 30 September 2026 pursuant to Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of Fortis Malar Hospitals Limited b5 We have reviewed the accompanying Statement of unaudited consolidated financial results of Fortis Malar Hospitals Limited (hereinafter referred to as “the Parent”), and its subsidiary (the Parent and its subsidiary together referred to as “the Group”) for the quarter ended 30 September 2026 and year to date results for the period from 01 April 2026 to 30 September 2026 (“the Statement”), being submitted by the Parent pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("Listing Regulations"). This Statement, which is the responsibility of the Parent’s management and approved by the Parent’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 “Interim Financial Reporting” (“Ind AS 34”), prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 “Review of Interim Financial Information Performed by the Independent Auditor of the Entity”, issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the Securities and Exchange Board of India under Regulation 33(8) of the Listing Regulations, to the extent applicable. The Statement includes the results of the following entities: a. Fortis Malar Hospitals Limited b. Fortis Healthcare Research Foundation (formerly known as Malar Stars Medicare Limited) Based on our review conducted and procedures performed as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. Registered Offce: 85 R Co {8 partnership firm with Ragistrtion No BAS1223) converted nto 8 R& Co P [ Limied 24th Floor, Cantal B Wing and Nerth C Wing, Nesco I Park 4, Nesco Center, Liabiity Partnarship with LL? RegstatioNno. AAB-8181) with affect from Octaber 16, 2013 Western Express Highway, Goregaon (East), Mumb- 4a000i63 Page 1 of 2 BSR&CoLL.P Limited Review Report (Continued) Fortis Malar Hospitals Limited 6. We draw attention to Note 7 to the Statement which explains that consequent to sale of business operations through a slump sale transaction, the Parent ceases to have any business operations. While there is no visibility of commencing any new business operations in the future, the Parent's management and Board of Directors is currently evaluating various corporate restructuring options for the future possible course of actions for the Parent and is progressing with the finalisation of plan. However, the Parent believes that it has sufficient cash and cash equivalent and other bank balances to settle its obligations as and when they fall due, and it believes that it would be able to meet its financial requirements for the foreseeable future based on the current cash position and projected cash flows. Accordingly, these unaudited consolidated financial results have been prepared on a going concern basis. Our conclusion is not modified in respect of this matter. ForBSR & Co. LLP Chartered Accountants Firm’s Registration No.:101248W/W-100022 n\(umar Tyagi ' Partner Gurugram Membership No.: 518152 03 November 2026 UDIN: 265181525YVIMS3524 Page 2 0f2 BSR&Co. LLP DLFC averciy Prasen Gurugram - 122 002, India Chartered Accountants Tel: +91 124 719 1000 Fax: +91 124 235 8613 Limited Review Report on unaudited standalone financial results of Fortis Malar Hospitals Limited for the quarter ended 30 September 2026 and year to date results for the period from 1 April 2026 to 30 September 2026 pursuant to Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of Fortis Malar Hospitals Limited B s We have reviewed the accompanying Statement of unaudited standalone financial results of Fortis Malar Hospitals Limited (hereinafter referred to as “the Company”) for the quarter ended 30 September 2026 and year to date results for the period from 1 April 2026 to 30 September 2026 (“the Statement”). This Statement, which is the responsibility of the Company’s management and approved by its Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 “Interim Financial Reporting” (“Ind AS 34”), prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“Listing Regulations”). Our [Showing first 8,000 characters — download PDF for full document]